Literature DB >> 12438686

A genomic-scale view of the cAMP response element-enhancer decoy: a tumor target-based genetic tool.

Yee Sook Cho1, Meyoung-Kon Kim, Chris Cheadle, Catherine Neary, Yun Gyu Park, Kevin G Becker, Yoon S Cho-Chung.   

Abstract

Enhancer DNA decoy oligodeoxynucleotides (ODNs) inhibit transcription by competing for transcription factors. A decoy ODN composed of the cAMP response element (CRE) inhibits CRE-directed gene transcription and tumor growth without affecting normal cell growth. Here, we use DNA microarrays to analyze the global effects of the CRE-decoy ODN in cancer cell lines and in tumors grown in nude mice. The CRE-decoy up-regulates the AP-2beta transcription factor gene in tumors but not in the livers of host animals. The up-regulated expression of AP-2beta is clustered with the up-regulation of other genes involved in development and cell differentiation. Concomitantly, another cluster of genes involved in cell proliferation and transformation is down-regulated. The observed alterations indicate that CRE-directed transcription favors tumor growth. The CRE-decoy ODN, therefore, may serve as a target-based genetic tool to treat cancer and other diseases in which CRE-directed transcription is abnormally used.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12438686      PMCID: PMC137767          DOI: 10.1073/pnas.242617799

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  33 in total

1.  CREB: a Ca(2+)-regulated transcription factor phosphorylated by calmodulin-dependent kinases.

Authors:  M Sheng; M A Thompson; M E Greenberg
Journal:  Science       Date:  1991-06-07       Impact factor: 47.728

2.  Growth arrest and induction of apoptosis in breast cancer cells by antisense depletion of protein kinase A-RI alpha subunit: p53-independent mechanism of action.

Authors:  R K Srivastava; A R Srivastava; P Seth; S Agrawal; Y S Cho-Chung
Journal:  Mol Cell Biochem       Date:  1999-05       Impact factor: 3.396

3.  A family of immunologically related transcription factors that includes multiple forms of ATF and AP-1.

Authors:  T W Hai; F Liu; E A Allegretto; M Karin; M R Green
Journal:  Genes Dev       Date:  1988-10       Impact factor: 11.361

4.  Quantitative monitoring of gene expression patterns with a complementary DNA microarray.

Authors:  M Schena; D Shalon; R W Davis; P O Brown
Journal:  Science       Date:  1995-10-20       Impact factor: 47.728

5.  CpG motifs in bacterial DNA trigger direct B-cell activation.

Authors:  A M Krieg; A K Yi; S Matson; T J Waldschmidt; G A Bishop; R Teasdale; G A Koretzky; D M Klinman
Journal:  Nature       Date:  1995-04-06       Impact factor: 49.962

6.  A dominant repressor of cyclic adenosine 3',5'-monophosphate (cAMP)-regulated enhancer-binding protein activity inhibits the cAMP-mediated induction of the somatostatin promoter in vivo.

Authors:  K M Walton; R P Rehfuss; J C Chrivia; J E Lochner; R H Goodman
Journal:  Mol Endocrinol       Date:  1992-04

7.  Binding of a nuclear protein to the cyclic-AMP response element of the somatostatin gene.

Authors:  M R Montminy; L M Bilezikjian
Journal:  Nature       Date:  1987 Jul 9-15       Impact factor: 49.962

8.  Activation of cAMP and mitogen responsive genes relies on a common nuclear factor.

Authors:  J Arias; A S Alberts; P Brindle; F X Claret; T Smeal; M Karin; J Feramisco; M Montminy
Journal:  Nature       Date:  1994-07-21       Impact factor: 49.962

9.  Phosphorylated CREB binds specifically to the nuclear protein CBP.

Authors:  J C Chrivia; R P Kwok; N Lamb; M Hagiwara; M R Montminy; R H Goodman
Journal:  Nature       Date:  1993-10-28       Impact factor: 49.962

10.  Transcriptional activation by Myc is under negative control by the transcription factor AP-2.

Authors:  S Gaubatz; A Imhof; R Dosch; O Werner; P Mitchell; R Buettner; M Eilers
Journal:  EMBO J       Date:  1995-04-03       Impact factor: 11.598

View more
  5 in total

1.  Targeting CREB for cancer therapy: friend or foe.

Authors:  Xiangshu Xiao; Bingbing X Li; Bryan Mitton; Alan Ikeda; Kathleen M Sakamoto
Journal:  Curr Cancer Drug Targets       Date:  2010-06       Impact factor: 3.428

Review 2.  Nucleic acid-based approaches to STAT inhibition.

Authors:  Malabika Sen; Jennifer R Grandis
Journal:  JAKSTAT       Date:  2012-10-01

Review 3.  Anti-apoptotic effect of Tax: an NF-κB path or a CREB way?

Authors:  Daniela Saggioro
Journal:  Viruses       Date:  2011-06-27       Impact factor: 5.048

4.  Small molecule nAS-E targeting cAMP response element binding protein (CREB) and CREB-binding protein interaction inhibits breast cancer bone metastasis.

Authors:  Min Jiang; Yufei Yan; Kai Yang; Zhuochao Liu; Jin Qi; Hanbing Zhou; Niandong Qian; Qi Zhou; Tianqi Wang; Xing Xu; Xiangshu Xiao; Lianfu Deng
Journal:  J Cell Mol Med       Date:  2018-11-20       Impact factor: 5.310

5.  SS18-SSX drives CREB activation in synovial sarcoma.

Authors:  Magdalene Cyra; Miriam Schulte; Ruth Berthold; Lorena Heinst; Esther-Pia Jansen; Inga Grünewald; Sandra Elges; Olle Larsson; Christoph Schliemann; Konrad Steinestel; Susanne Hafner; Thomas Simmet; Eva Wardelmann; Sareetha Kailayangiri; Claudia Rossig; Ilka Isfort; Marcel Trautmann; Wolfgang Hartmann
Journal:  Cell Oncol (Dordr)       Date:  2022-05-12       Impact factor: 7.051

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.